InvestorsHub Logo
Followers 4
Posts 201
Boards Moderated 0
Alias Born 03/06/2022

Re: Jonjones325 post# 453265

Sunday, 03/03/2024 9:47:00 PM

Sunday, March 03, 2024 9:47:00 PM

Post# of 458947
Why didn't the small group of 5%-15% make the cut? Well, if LEQEMBI fails at the EMA in the next couple of months after a review by an SAG called in to render an opinion, we can say that one of the applicants (or about 1% of total, as I recall) did not pass in terms of the efficacy/safety ratio and/or an efficacy/cost ratio.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News